G. Gatta, J.M. van der Zwan, P.G. Casali, S. Siesling, A.P. Dei Tos, I. Kunkler, R. Otter, L. Licitra, S. Mallone, A. Tavilla, A. Trama, R. Capocaccia, R.w. group, rare cancers are not so rare: the rare cancer burden in Europe. Eur. J. Cancer. 47(17), 2493–2511 (2011)

Article  PubMed  Google Scholar 

C.E. DeSantis, J.L. Kramer, A. Jemal, The burden of rare cancers in the United States. CA Cancer J. Clin. 67(4), 261–272 (2017)

PubMed  Google Scholar 

G. Gatta, L. Ciccolallo, I. Kunkler, R. Capocaccia, F. Berrino, M.P. Coleman, R. De Angelis, J. Faivre, J.M. Lutz, C. Martinez, T. Moller, R. Sankila, E.W. Group, Survival from rare cancer in adults: a population-based study. Lancet Oncol. 7(2), 132–140 (2006)

Article  PubMed  Google Scholar 

G. Gatta, R. Capocaccia, L. Botta, S. Mallone, R. De Angelis, E. Ardanaz, H. Comber, N. Dimitrova, M.K. Leinonen, S. Siesling, J.M. van der Zwan, L. Van Eycken, O. Visser, M.P. Zakelj, L.A. Anderson, F. Bella, I. Kaire, R. Otter, C.A. Stiller, A. Trama, R.A.w. group, burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study. Lancet Oncol. 18(8), 1022–1039 (2017)

Article  PubMed  Google Scholar 

J.Y. Blay, J.M. Coindre, F. Ducimetiere, I. Ray-Coquard, The value of research collaborations and consortia in rare cancers. Lancet Oncol. 17(2), e62–e9 (2016)

Article  PubMed  Google Scholar 

K.M. Komatsubara, R.D. Carvajal, The promise and challenges of rare cancer research. Lancet Oncol. 17(2), 136–138 (2016)

Article  PubMed  Google Scholar 

A.M. Frezza, A. Trama, J.Y. Blay, P.G. Casali, Networking in rare cancers: what was done, what’s next. Eur. J. Surg. Oncol. 45(1), 16–18 (2019)

Article  PubMed  Google Scholar 

J. Lu, Y. Li, J. Wang, S. Cell (Neuroendocrine) Carcinoma of the Cervix (eds.), An Analysis for 19 Cases and Literature Review. Front Cell Infect Microbiol. 12916506 (2022)

C. Le Tourneau, J.P. Delord, A. Goncalves, C. Gavoille, C. Dubot, N. Isambert, M. Campone, O. Tredan, M.A. Massiani, C. Mauborgne, S. Armanet, N. Servant, I. Bieche, V. Bernard, D. Gentien, P. Jezequel, V. Attignon, S. Boyault, A. Vincent-Salomon, V. Servois, M.P. Sablin, M. Kamal, X. Paoletti, investigators, molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial. Lancet Oncol. 16(13), 1324–1334 (2015)

Article  PubMed  Google Scholar 

J. Marquart, E.Y. Chen, V. Prasad, Estimation of the percentage of US patients with cancer who benefit from Genome-Driven oncology. JAMA Oncol. 4(8), 1093–1098 (2018)

Article  PubMed  PubMed Central  Google Scholar 

J. Munoz, R. Kurzrock, Targeted therapy in rare cancers–adopting the orphans. Nat. Rev. Clin. Oncol. 9(11), 631–642 (2012)

Article  CAS  PubMed  Google Scholar 

N. Boyd, J.E. Dancey, C.B. Gilks, D.G. Huntsman, Rare cancers: a sea of opportunity. Lancet Oncol. 17(2), e52–e61 (2016)

Article  PubMed  Google Scholar 

T. Kondo, Current status and future outlook for patient-derived cancer models from a rare cancer research perspective. Cancer Sci. 112(3), 953–961 (2021)

Article  CAS  PubMed  PubMed Central  Google Scholar 

S. Vivekanandhan, D. Bahr, A. Kothari, M.A. Ashary, M. Baksh, E. Gabriel, Immunotherapies in rare cancers. Mol. Cancer. 22(1), 23 (2023)

Article  PubMed  PubMed Central  Google Scholar 

J. Drost, H. Clevers, Organoids in cancer research. Nat. Rev. Cancer. 18(7), 407–418 (2018)

Article  CAS  PubMed  Google Scholar 

V. Veninga, E.E. Voest, Tumor organoids: opportunities and challenges to guide precision medicine. Cancer Cell. 39(9), 1190–1201 (2021)

Article  CAS  PubMed  Google Scholar 

J.T. Neal, X. Li, J. Zhu, V. Giangarra, C.L. Grzeskowiak, J. Ju, I.H. Liu, S.H. Chiou, A.A. Salahudeen, A.R. Smith, B.C. Deutsch, L. Liao, A.J. Zemek, F. Zhao, K. Karlsson, L.M. Schultz, T.J. Metzner, L.D. Nadauld, Y.Y. Tseng, S. Alkhairy, C. Oh, P. Keskula, D. Mendoza-Villanueva, F.M. De La Vega, P.L. Kunz, J.C. Liao, J.T. Leppert, J.B. Sunwoo, C. Sabatti, J.S. Boehm, W.C. Hahn, G.X.Y. Zheng, M.M. Davis, C.J., Kuo, Organoid modeling of the tumor immune microenvironment. Cell. 175(7), 1972-88 e16 (2018)

Z. Zhou, Y. Pang, J. Ji, J. He, T. Liu, L. Ouyang, W. Zhang, X.L. Zhang, Z.G. Zhang, K. Zhang, W. Sun, Harnessing 3D in vitro systems to model immune responses to solid tumours: a step towards improving and creating personalized immunotherapies. Nat. Rev. Immunol. 24(1), 18–32 (2024)

Article  CAS  PubMed  Google Scholar 

K.K. Dijkstra, C.M. Cattaneo, F. Weeber, M. Chalabi, J. van de Haar, L.F. Fanchi, M. Slagter, D.L. van der Velden, S. Kaing, S. Kelderman, N. van Rooij, M.E. van Leerdam, A. Depla, E.F. Smit, K.J. Hartemink, R. de Groot, M.C. Wolkers, N. Sachs, P. Snaebjornsson, K. Monkhorst, J. Haanen, H. Clevers, T.N. Schumacher, E.E. Voest, Generation of tumor-reactive T cells by co-culture of peripheral blood lymphocytes and tumor organoids. Cell. 174(6), 1586–98 e12 (2018)

Z. Wang, H.P. McWilliams-Koeppen, H. Reza, J.R. Ostberg, W. Chen, X. Wang, C. Huynh, V. Vyas, W.C. Chang, R. Starr, J.R. Wagner, B. Aguilar, X. Yang, X. Wu, J. Wang, W. Chen, E. Koelker-Wolfe, C.S. Seet, A. Montel-Hagen, G.M. Crooks, S.J. Forman, C.E. Brown, 3D-organoid culture supports differentiation of human CAR(+) iPSCs into highly functional CAR T cells. Cell. 29(4), 515 – 27 e8 (2022)

A. Chao, R.C. Wu, C.Y. Lin, T.C. Chang, C.H. Lai, Small cell neuroendocrine carcinoma of the cervix: from molecular basis to therapeutic advances. Biomed. J. 46(5), 100633 (2023)

Article  CAS  PubMed  PubMed Central  Google Scholar 

S. Uccella, S. La Rosa, J. Metovic, D. Marchiori, J.Y. Scoazec, M. Volante, O. Mete, M. Papotti, Genomics of High-Grade neuroendocrine neoplasms: Well-Differentiated neuroendocrine tumor with High-Grade features (G3 NET) and neuroendocrine carcinomas (NEC) of various anatomic sites. Endocr. Pathol. 32(1), 192–210 (2021)

Article  PubMed  Google Scholar 

V. Melone, A. Salvati, D. Palumbo, G. Giurato, G. Nassa, F. Rizzo, L. Palo, A. Giordano, M. Incoronato, M. Vitale, C. Mian, I. Di Biase, S. Cristiano, V. Narciso, M. Cantile, A. Di Mauro, F. Tatangelo, S. Tafuto, R. Modica, C. Pivonello, M. Salvatore, A. Colao, A. Weisz, R. Tarallo, Identification of functional pathways and molecular signatures in neuroendocrine neoplasms by multi-omics analysis. J. Transl Med. 20(1), 306 (2022)

Article  CAS  PubMed  PubMed Central  Google Scholar 

N. Cancer Genome Atlas Research, M. Albert Einstein College of, S. Analytical Biological, H. Barretos Cancer, M. Baylor College of, H. Beckman Research Institute of City of, A. Buck Institute for Research on, C. Canada's Michael Smith Genome Sciences, S. Harvard Medical, F.G.C.C. Helen, S. Research Institute at Christiana Care Health, B. HudsonAlpha Institute for, L.L.C. Ilsbio, M. Indiana University School of, V. Institute of Human, B. Institute for Systems, C. International Genomics, B. Leidos, H. Massachusetts General, U. McDonnell Genome Institute at Washington, W. Medical College of, C. Medical University of South, C. Memorial Sloan Kettering Cancer, C. Montefiore Medical, NantOmics, I. National Cancer, A.N. National Hospital, I. National Human Genome Research, S. National Institute of Environmental Health, D. National Institute on, D. Other Communication, L.H.S.C. Ontario Tumour Bank, O.I.f.C.R. Ontario Tumour Bank, T.O.H. Ontario Tumour Bank, H. Oregon, U. Science, C.-S.M.C. Samuel Oschin Comprehensive Cancer Institute, S.R.A. International, S. St Joseph's Candler Health, Eli, L.B.I.o.M.I.o.T. Edythe, U. Harvard, H. Research Institute at Nationwide Children's, U. Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, B. University of, M.D.A.C.C. University of Texas, H. University of Abuja Teaching, B. University of Alabama at, I. University of California, C. University of California Santa, C. University of Kansas Medical, L. University of, C. University of New Mexico Health Sciences, H. University of North Carolina at Chapel, C. University of Oklahoma Health Sciences, P. University of, R.a.P.M.S. University of Sao Paulo, C. University of Southern, W. University of, M. University of Wisconsin School of, H. Public, I. Van Andel Research, L. Washington University in St, Integrated genomic and molecular characterization of cervical cancer. Nature. 543(7645), 378–84 (2017)

L. Jiang, J. Huang, B.W. Higgs, Z. Hu, Z. Xiao, X. Yao, S. Conley, H. Zhong, Z. Liu, P. Brohawn, D. Shen, S. Wu, X. Ge, Y. Jiang, Y. Zhao, Y. Lou, C. Morehouse, W. Zhu, Y. Sebastian, M. Czapiga, V. Oganesyan, H. Fu, Y. Niu, W. Zhang, K. Streicher, D. Tice, H. Zhao, M. Zhu, L. Xu, R. Herbst, X. Su, Y. Gu, S. Li, L. Huang, J. Gu, B. Han, B. Jallal, H. Shen, Y. Yao, Genomic landscape survey identifies SRSF1 as a key oncodriver in small cell lung cancer. PLoS Genet. 12(4), e1005895 (2016)

Z. Sondka, N.B. Dhir, D. Carvalho-Silva, S. Jupe, Madhumita, K. McLaren, M. Starkey, S. Ward, J. Wilding, M. Ahmed, J. Argasinska, D. Beare, M.S. Chawla, S. Duke, I. Fasanella, A.G. Neogi, S. Haller, B. Hetenyi, L. Hodges, A. Holmes, R. Lyne, T. Maurel, S. Nair, H. Pedro, A. Sangrador-Vegas, H. Schuilenburg, Z. Sheard, S.Y. Yong, J. Teague, COSMIC: a curated database of somatic variants and clinical data for cancer. Nucleic Acids Res. 52(D1), D1210–D7 (2024)

B. Vogelstein, N. Papadopoulos, V.E. Velculescu, S. Zhou, L.A. Jr. Diaz, K.W. Kinzler, Cancer genome landscapes. Science. 339(6127), 1546–1558 (2013)

Article  CAS  PubMed  PubMed Central  Google Scholar 

C. Kandoth, M.D. McLellan, F. Vandin, K. Ye, B. Niu, C. Lu, M. Xie, Q. Zhang, J.F. McMichael, M.A. Wyczalkowski, M.D.M. Leiserson, C.A. Miller, J.S. Welch, M.J. Walter, M.C. Wendl, T.J. Ley, R.K. Wilson, B.J. Raphael, L. Ding, Mutational landscape and significance across 12 major cancer types. Nature. 502(7471), 333–339 (2013)

Article  CAS  PubMed  PubMed Central  Google Scholar 

T.L. Dayton, N. Alcala, L. Moonen, L. den Hartigh, V. Geurts, L. Mangiante, L. Lap, A.F.M. Dost, J. Beumer, S. Levy, R.S. van Leeuwaarde, W.M. Hackeng, K. Samsom, C. Voegele, A. Sexton-Oates, H. Begthel, J. Korving, L. Hillen, L.A.A. Brosens, S. Lantuejoul, S. Jaksani, N.F.M. Kok, K.J. Hartemink, H.M. Klomp, I.H.M. Borel Rinkes, A.M. Dingemans, G.D. Valk, M.R. Vriens, W. Buikhuisen, J. van den Berg, M. Tesselaar, J. Derks, E.J. Speel, M. Foll, L. Fernandez-Cuesta, H. Clevers, Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites. Cancer Cell. 41(12), 2083–99 e9 (2023)

W. Yang, J. Soares, P. Greninger, E.J. Edelman, H. Lightfoot, S. Forbes, N. Bindal, D. Beare, J.A. Smith, I.R. Thompson, S. Ramaswamy, P.A. Futreal, D.A. Haber, M.R. Stratton, C. Benes, U. McDermott, M.J. Garnett, Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 41(Database issue), D955–61 (2013)

S. Krishna, F.J. Lowery, A.R. Copeland, E. Bahadiroglu, R. Mukherjee, L. Jia, J.T. Anibal, A. Sachs, S.O. Adebola, D. Gurusamy, Z. Yu, V. Hill, J.J. Gartner, Y.F. Li, M. Parkhurst, B. Paria, P. Kvistborg, M.C. Kelly, S.L. Goff, G. Altan-Bonnet, P.F. Robbins, Rosenberg, Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer. Science. 370(6522), 1328–1334 (2020)

Article  CAS  PubMed  PubMed Central  Google Scholar 

N. Levin, B.C. Paria, N.R. Vale, R. Yossef, F.J. Lowery, M.R. Parkhurst, Z. Yu, M. Florentin, G. Cafri, J.J. Gartner, M.L. Shindorf, L.T. Ngo, S. Ray, S.P. Kim, A.R. Copeland, P.F. Robbins, S.A. Rosenberg, Identification and validation of T-cell receptors targeting RAS hotspot mutations in human cancers for use in Cell-based immunotherapy. Clin. Cancer Res. 27(18), 5084–5095 (2021)

Article  CAS  PubMed  PubMed Central  Google Scholar 

B.C. Paria, N. Levin, F.J. Lowery, A. Pasetto, D.C. Deniger, M.R. Parkhurst, R. Yossef, S.P. Kim, M. Florentin, L.T. Ngo, S. Ray, S. Krishna, P.F. Robbins, S.A. Rosenberg, Rapid identification and evaluation of Neoantigen-reactive T-Cell receptors from single cells. J. Immunother. 44(1), 1–8 (2021)

Article  CAS  PubMed  PubMed Central  Google Scholar 

M.A. Eiva, D.K. Omran, J.A. Chacon, D.J. Jr. Powell, Systematic analysis of CD39, CD103, CD137, and PD-1 as biomarkers for naturally occurring tumor antigen-specific TILs. Eur. J. Immunol. 52(1), 96–108 (2022)

Article  CAS  PubMed  Google Scholar 

P. Voabil, M. de Bruijn, L.M. Roelofsen, S.H. Hendriks, S. Brokamp, M. van den Braber, A. Broeks, J. Sanders, P. Herzig, A. Zippelius, C.U. Blank, K.J. Hartemink, K. Monkhorst, J. Haanen, T.N. Schumacher, D.S. Thommen, An ex vivo tumor fragment platform to dissect response to PD-1 Blockade in cancer. Nat. Med. 27(7), 1250–1261 (2021)

Article